Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.
Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ... Change value during the period between open outcry settle and the ...
Moleculin Biotech stock surged on ... the size of Part B of our trial by approximately 10%. Moreover, the nature of the feedback helps us move forward quickly to open sites in the US, in addition ...
Further trial details can be found on ClinicalTrials.gov. The surge in AnaptysBio's stock price reflects investor confidence in the potential of rosnilimab to become a significant player in the RA ...
Eli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the stock market ... also expects Phase 3 trial readouts of its oral ...
ATLANTA, Feb. 13, 2025 /PRNewswire/ -- Court TV's new, seven-part original limited series, "Trial & Error: Why Did O.J. Win?" debuts on Sunday, Feb. 16 at 8 p.m. ET/PT. The series takes a deep dive ...
BUENOS AIRES (Reuters) - Argentine President Javier Milei could face an impeachment trial in Congress, opposition lawmakers said on Saturday, after the libertarian leader touted a cryptocurrency ...
U.S. stock markets will be closed on Monday, Feb. 17, in observance of the Presidents Day holiday, also known as Washington's Birthday. The Nasdaq and New York Stock Exchange will both be ...
George Washington (and the holiday is still designated as Washington’s Birthday on the federal and New York Stock Exchange calendars). It’s always observed on the third Monday in February ...
Moderna's stock was down 5% in premarket trading on the earnings results but rose more than 2% sharply after the opening bell. Moderna reported $966 million in fourth quarter revenue, beating Wall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback